EP1356827A1 — Method for obtaining a 2-18F-fluor-2-deoxy-D-glucose (18F-FDG)-solution
Assigned to Mallinckrodt Inc · Expires 2003-10-29 · 23y expired
What this patent protects
The invention relates to a method for improving one or more physical/chemical characteristics, like reduced radiolysis of and the ability to autoclave, a 18 F-fluor-deoxy-glucose ( 18 F-FDG)-solution, which method comprises the steps of a) provision of a 18 F-fluor-deoxy-glucos…
USPTO Abstract
The invention relates to a method for improving one or more physical/chemical characteristics, like reduced radiolysis of and the ability to autoclave, a 18 F-fluor-deoxy-glucose ( 18 F-FDG)-solution, which method comprises the steps of a) provision of a 18 F-fluor-deoxy-glucose ( 18 F-FDG)-solution, and b) addition of at least one buffer based on a weak acid to the 18 F-fluor-deoxy-glucose ( 18 F-FDG)-solution. The invention also relates to a method for preparing a sterile 18 F-fluor-deoxy-glucose ( 18 F-FDG)-solution by autoclaving said 18 F-fluor-deoxy-glucose (FDG)-solution.
Drugs covered by this patent
- Posluma (FLOTUFOLASTAT F-18 GALLIUM) · Blue Earth
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.